drugset / Trial / NCT01555866
Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
Phase 1
Completed
49 enrolled
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd · collab
Non-randomizedParallel-groupOpen-label
Summary
This is a 2-part, open-label study, designed to evaluate the effect of renal disease on the pharmacokinetics of BAL4815 (active isavuconazole moiety) relative to the pharmacokinetics in healthy subjects with normal renal function.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isavuconazole | Small molecule | — | — |